ARTICLE
|
doi:10.20944/preprints202410.1687.v1
Subject:
Public Health And Healthcare,
Health Policy And Services
Keywords:
pharmaceutical policy; innovative medicines; social loss; reimbursement delays; health economics; quality-adjusted life years (QALYs)
Online: 24 October 2024 (10:24:09 CEST)